BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

HanchorBio Partners with Taiwan Cancer Moonshot Team to Advance Precision Immunotherapy

Collaboration connects internationally recognized cancer multi-omics research with HanchorBio's clinical-stage immuno-oncology platform to accelerate bioma...

August 11, 2026 | News

Pathos AI Secures Up to $2.2 Billion Global Licensing Deal for Alphamab's First-in-Class Bispecific ADC

Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a licensing agreement with Jiangsu Al...

August 06, 2026 | News

GlycoNex Doses First Patient in Phase I Trial of Novel Glycan-Targeting ADC GNX1021

GlycoNex Inc. announced that the first patient has been successfully dosed in the First-in-Human (FIH) Phase I clinical trial of GNX1021, the Company's nov...

August 04, 2026 | News

AnHorn Medicines Advances First-in-Class AH-008 into Phase I Trial for Chemotherapy-Induced Neuropathy Prevention

AnHorn Medicines announced the successful completion of the first subject first dose in the Phase I clinical trial of AH-008, a first-in-class neuroprotect...

July 27, 2026 | News

Menarini Asia-Pacific, Pharmacosmos Partner to Expand Cosela® Access Across APAC

Menarini Asia-Pacific announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distribute Cosela® (trilaciclib) acr...

July 23, 2026 | News

Poland and Taiwan Turn Biotech Dialogue into Partnership at BIO Asia–Taiwan 2026

Poland and Taiwan moved to strengthen their biotechnology relationship at the Poland–Taiwan Biotechnology Forum, held on 17 July during BIO A...

July 20, 2026 | News

Canada and Taiwan Build New Bridges Across AI, Advanced Therapeutics and Precision Health

As biotechnology increasingly converges with artificial intelligence, advanced therapeutics and data-driven healthcare, the next generation of inno...

July 20, 2026 | News

Why Korea, Why Now? Korean Biotech Looks to Taiwan as Asia’s Next Partnership Frontier

Korea’s biotechnology industry is entering a new phase of global ambition. Having established significant capabilities across biopharmaceutical manuf...

July 20, 2026 | News

Japan Looks Beyond Its Borders to Build the Next Generation of Biotech Innovation

Japan’s biotechnology sector is entering a new phase in which scientific strength alone may no longer determine success. As drug development becomes ...

July 20, 2026 | News

Malaysia Positions Biotechnology as a Bridge Between Asian Innovation and Global Markets

As Asia’s biotechnology sector moves from scientific capability towards commercial scale, Malaysia is positioning itself as an increasingly i...

July 20, 2026 | News

India’s Life Sciences Proposition Expands from Global Scale to Strategic Innovation

India’s position in the global life sciences economy has long been anchored in scale — from active pharmaceutical ingredients (APIs) and generi...

July 20, 2026 | News

The Netherlands Positions Itself as Europe’s Gateway for Life Sciences Innovation

For biotechnology companies looking towards Europe, the opportunity is considerable—but so is the complexity. Accessing one of the world’s larg...

July 20, 2026 | News

Hong Kong Makes Its Case as Asia’s Biotech Super-Connector: Capital, Regulation and Scale Converge

Hong Kong is seeking to redefine its place in the global life sciences economy. No longer content to be viewed primarily as a financial gateway int...

July 20, 2026 | News

Australia and Taiwan Build a Faster Clinical Bridge for Global Biotech Development

As biotechnology companies face mounting pressure to move promising science into human studies faster, the relationship between Australia and Taiwa...

July 20, 2026 | News

Stay Connected